Clinical Trials Browser

Phase 2 × Medulloblastoma × HhAntag691 × Clear all

NCT01878617 2025-11-13

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

Phase 2 Active not recruiting

Brain Neoplasms, Medulloblastoma, Infratentorial Neoplasms, Neuroectodermal Tumors, Primitive

NCT01239316 2016-01-14

Vismodegib in Treating Younger Patients With Recurrent or Refractory Medulloblastoma

Phase 2 Completed

12 enrolled 11 charts

Medulloblastoma